IL2 and myeloid sarcoma: Together with the changes in the composition of the circulating mononuclear phagocyte population, this indicates that a cytokine dysregulation characterized by activation of the IL-2RA–IL-2–GM-CSF axis, triggered by a unique environmental challenge, may well be the immunological substrate for disease initiation and/or progression in MS.